Fennec Pharmaceuticals (TSE:FRX) has released an update.
Fennec Pharmaceuticals Inc. has filed a current report with the SEC, as documented in their latest Form 8-K. The report, dated March 15, 2024, details the company’s recent updates, which are pertinent to investors and stakeholders. Fennec Pharmaceuticals, traded under the symbol FENC on the Nasdaq Capital Market, maintains its principal executive offices in Research Triangle Park, NC.
For further insights into TSE:FRX stock, check out TipRanks’ Stock Analysis page.
